GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » Piotroski F-Score

Center Laboratories (ROCO:4123) Piotroski F-Score : 5 (As of Apr. 13, 2025)


View and export this data going back to 2003. Start your Free Trial

What is Center Laboratories Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Center Laboratories has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Center Laboratories's Piotroski F-Score or its related term are showing as below:

ROCO:4123' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 5   Max: 7
Current: 5

During the past 13 years, the highest Piotroski F-Score of Center Laboratories was 7. The lowest was 1. And the median was 5.


Center Laboratories Piotroski F-Score Historical Data

The historical data trend for Center Laboratories's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Center Laboratories Piotroski F-Score Chart

Center Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 3.00 5.00 3.00 5.00

Center Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 4.00 5.00 5.00

Competitive Comparison of Center Laboratories's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Center Laboratories's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Center Laboratories's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was -540.977 + -72.469 + 273.31 + -763.547 = NT$-1,104 Mil.
Cash Flow from Operations was 124.252 + 9.403 + 102.918 + 179.142 = NT$416 Mil.
Revenue was 363.41 + 413.419 + 392.486 + 448.554 = NT$1,618 Mil.
Gross Profit was 164.675 + 191.017 + 182.105 + 211.156 = NT$749 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(27002.156 + 27091.537 + 27049.569 + 26027.63 + 25537.175) / 5 = NT$26541.6134 Mil.
Total Assets at the begining of this year (Dec23) was NT$27,002 Mil.
Long-Term Debt & Capital Lease Obligation was NT$2,663 Mil.
Total Current Assets was NT$3,782 Mil.
Total Current Liabilities was NT$4,617 Mil.
Net Income was 991.634 + -933.041 + -978.712 + -75.302 = NT$-995 Mil.

Revenue was 335.01 + 312.302 + 341.168 + 405.528 = NT$1,394 Mil.
Gross Profit was 140.57 + 142.455 + 152.206 + 182.863 = NT$618 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(25187.646 + 27711.919 + 27638.065 + 27015.587 + 27002.156) / 5 = NT$26911.0746 Mil.
Total Assets at the begining of last year (Dec22) was NT$25,188 Mil.
Long-Term Debt & Capital Lease Obligation was NT$4,429 Mil.
Total Current Assets was NT$5,121 Mil.
Total Current Liabilities was NT$1,845 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Center Laboratories's current Net Income (TTM) was -1,104. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Center Laboratories's current Cash Flow from Operations (TTM) was 416. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=-1103.683/27002.156
=-0.04087388

ROA (Last Year)=Net Income/Total Assets (Dec22)
=-995.421/25187.646
=-0.03952021

Center Laboratories's return on assets of this year was -0.04087388. Center Laboratories's return on assets of last year was -0.03952021. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Center Laboratories's current Net Income (TTM) was -1,104. Center Laboratories's current Cash Flow from Operations (TTM) was 416. ==> 416 > -1,104 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=2663.088/26541.6134
=0.10033633

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=4429.049/26911.0746
=0.1645809

Center Laboratories's gearing of this year was 0.10033633. Center Laboratories's gearing of last year was 0.1645809. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=3781.507/4616.762
=0.81908208

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=5121.336/1845.075
=2.77567904

Center Laboratories's current ratio of this year was 0.81908208. Center Laboratories's current ratio of last year was 2.77567904. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Center Laboratories's number of shares in issue this year was 725.144. Center Laboratories's number of shares in issue last year was 691.014. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=748.953/1617.869
=0.46292561

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=618.094/1394.008
=0.44339344

Center Laboratories's gross margin of this year was 0.46292561. Center Laboratories's gross margin of last year was 0.44339344. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=1617.869/27002.156
=0.05991629

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=1394.008/25187.646
=0.05534491

Center Laboratories's asset turnover of this year was 0.05991629. Center Laboratories's asset turnover of last year was 0.05534491. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+0+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Center Laboratories has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Center Laboratories  (ROCO:4123) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Center Laboratories Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Center Laboratories's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Center Laboratories Business Description

Traded in Other Exchanges
N/A
Address
No. 3-2, Park Street, 7th floor, Nangang District, Taipei, TWN
Center Laboratories Inc is active in the healthcare sector. The company is engaged in the manufacture and sale of various Western medicines. The segments include: Pharmaceutical Division which includes manufacturing and sales of various Western Medicines; Biotechnology Venture Capital consists Investing in domestic and foreign biotechnology undertakings; Glac segment - Manufacture and sale of probiotic products and others. It geographically operates in Taiwan, China and Others.

Center Laboratories Headlines

No Headlines